TELA Bio (TELA) Operating Expenses (2018 - 2026)

TELA Bio's Operating Expenses history runs 9 years deep, the most recent figure standing at $23.0 million for Q1 2026.

• In Q1 2026, Operating Expenses changed 0.27% year-over-year to $23.0 million; the TTM figure through Mar 2026 stood at $88.2 million (up 0.84% YoY), while the FY2025 annual figure was $88.1 million, changed 0.1% from the prior year.
• Operating Expenses was $23.0 million for Q1 2026 at TELA Bio, up from $20.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $23.9 million in Q4 2023 to a low of $14.8 million in Q1 2022.
• Historically, Operating Expenses has averaged $20.6 million across 5 years, with a median of $20.6 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses soared 42.19% in 2022, then retreated 18.1% in 2024.
• A 5-year view of Operating Expenses shows it stood at $17.6 million in 2022, then soared by 35.69% to $23.9 million in 2023, then declined by 18.1% to $19.6 million in 2024, then climbed by 4.23% to $20.4 million in 2025, then gained by 12.95% to $23.0 million in 2026.
• The last three Operating Expenses figures came in at $23.0 million (Q1 2026), $20.4 million (Q4 2025), and $21.5 million (Q3 2025), per Business Quant data.